NDC 11695-0072 - AceproTabs 25

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
11695-0072
Package NDCs from labels
11695-0072-1, 11695-0072-5
Manufacturer
Henry Schein Animal Health
Effective date
2018-06-01
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
AceproTabs 25 - Henry Schein Animal HealthHenry Schein Animal Health2018-06-01PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACEPROMAZINE MALEATEACTIVE INGREDIENT37862HP2OMACEPROTABS 25 (ACEPROMAZINE MALEATE) TABLET [HENRY SCHEIN ANIMAL HEALTH]2
ACEPROMAZINEACTIVE MOIETY54EJ303F0RACEPROTABS 25 (ACEPROMAZINE MALEATE) TABLET [HENRY SCHEIN ANIMAL HEALTH]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 7 · 129 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CPDA-1ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINEFenwal, Inc.14445dfd-6041-40cd-a043-3f4da6bcb9c12019-11-18Exact identifier
unii: LX22YL083G
CPDA-1ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINEFenwal, Inc.2557199a-5f60-49d8-b093-1e07002112432019-11-18Exact identifier
unii: LX22YL083G
CPDA-1ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINEFenwal, Inc.794f724c-87f0-49c1-9b26-c9e4919783132019-11-18Exact identifier
unii: LX22YL083G
CPDA-1ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINEFenwal, Inc.5c7d3287-883a-459b-9214-074a583c8a592019-11-18Exact identifier
unii: LX22YL083G
CPDA-1ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINEFenwal, Inc.448a1dc5-7a98-4b2f-82af-4b92de05cfc32019-11-18Exact identifier
unii: LX22YL083G
DEXTROSEDEXTROSE MONOHYDRATEBaxter Healthcare Corporation0332f34a-7038-47cc-ba59-d55cad6b73ca2019-08-05Warnings, Adverse reactionsExact identifier
unii: LX22YL083G
Potassium Chloride in DextrosePOTASSIUM CHLORIDE AND DEXTROSE MONOHYDRATEBaxter Healthcare Company45de5402-5e61-4bbd-8bbc-5e3392c9920e2019-07-15Warnings, Adverse reactionsExact identifier
unii: LX22YL083G
Potassium Chloride in Dextrose and Sodium ChloridePOTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE AND SODIUM CHLORIDEBaxter Healthcare Companyc553fed1-3de5-4826-8eff-633b5923bf0b2019-02-21Warnings, Adverse reactionsExact identifier
unii: LX22YL083G
CPDA-1ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINEFenwal, Inc.051f7347-5a76-4664-8fe2-e61b3dfcb0e42014-08-27Exact identifier
unii: LX22YL083G

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.